Braunamide 25mg Capsule Supplier USA | Pharmaceutical Exporter from India

Braunamide 25mg Capsule: Advanced Immunomodulatory Therapy for Oncology Care

Are you searching for a dependable Braunamide 25 mg capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced hematology and oncology medications. We maintain a high-authority, regulatory-compliant supply chain serving the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that life-saving cancer treatments reach healthcare providers with pharmaceutical-grade integrity and efficient global logistics.

Detailed Product Overview: What is Braunamide 25mg?

Braunamide 25mg is a high-potency oral capsule containing the active pharmaceutical ingredient Lenalidomide. It belongs to a class of drugs known as immunomodulatory agents (IMiDs). Braunamide is a critical therapeutic option used primarily to treat various types of blood cancers and bone marrow disorders by altering the immune system's response and directly inhibiting the growth of malignant cells.

The 25mg strength is a standardized dose used in both intensive treatment cycles and long-term maintenance therapy. Manufactured under strict quality controls in India, Braunamide 25mg represents world-class pharmaceutical engineering and adherence to international safety standards for oncology care.

Primary Therapeutic Indications: 

Braunamide 25 mg is clinically indicated for the management of:

1. Multiple Myeloma (MM): Used in combination with dexamethasone in patients who have received at least one prior therapy, or as maintenance therapy following autologous hematopoietic stem cell transplantation (auto-HSCT).

2. Myelodysplastic Syndromes (MDS): Specifically for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

3. Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.

4. Follicular Lymphoma (FL): Used in combination with a rituximab product for previously treated adult patients.

Mechanism of Action: How Braunamide 25 mg Works: 

Braunamide (Lenalidomide) utilizes a multifaceted approach to combat malignant cells:

• Immune System Modulation: It stimulates the activity of the body's natural killer (NK) cells and T-cells, enhancing the "seek and destroy" capabilities of the immune system against cancer.

• Anti-Angiogenesis: It blocks the formation of new blood vessels that tumors require to grow, effectively starving the tumor of nutrients.

• Direct Tumor Inhibition: It triggers cell cycle arrest and apoptosis (programmed cell death) in malignant cells by interfering with their internal signaling and protein degradation pathways.

Administration and Safety Guidelines

• Standard Dosage: Typically taken as one 25mg capsule daily on specific days of a 21-day or 28-day cycle, as strictly directed by a consultant oncologist.

• Instructions: Capsules must be swallowed whole with water. Do not break, chew, or open the capsules. It can be taken with or without food.

• Key Precautions:

• Pregnancy: Lenalidomide is structurally related to thalidomide and can cause severe, life-threatening birth defects. Strict adherence to pregnancy prevention programs is mandatory.

• Blood Monitoring: Regular Complete Blood Counts (CBC) are necessary to monitor for potential side effects like neutropenia or thrombocytopenia.

• Thrombosis Risk: Patients may require prophylactic anticoagulation therapy to prevent venous thromboembolism (blood clots).

Why Source Braunamide 25 mg from Ernest Oncology?

• Strategic Indian Exporter: Direct access to high-quality manufacturing, ensuring 100% authenticity and cost-effective bulk pricing for international B2B markets.

• Global Distribution Reach: Expertise in navigating the regulatory and customs landscapes of the UK, USA, UAE, Australia, and South Africa.

• Bulk Supply Reliability: We specialize in large-scale exports for oncology hospitals, ensuring treatment continuity and preventing supply chain gaps.

• Secure Logistics: Professional packaging and tracked shipping to maintain the chemical stability and safety of the medication during transit.